Mawendo

What Mawendo does

Mawendo GmbH operates a 12-week, web-based digital health application (DiGA) for orthopedic rehabilitation, founded in 2013 by Johannes Merg, Daniel Wagner, and Michael Merg. The product is CE-certified as a Class I medical device (Medizinprodukt Risikoklasse 1) and listed in the German statutory health insurance reimbursement regime (gesetzliche Krankenversicherung) for M22 patellar indications, with an active pipeline of additional orthopedic diagnoses. The therapy program covers 18+ orthopedic conditions spanning knee, shoulder, hip, elbow, ankle, spine, and foot, structured in three progressive phases and grounded in guidelines from five German specialty societies (DGOU, AGA, DVSE, DKG, DAF) and 100+ cited scientific works.

The underlying platform is browser-based, accessible via desktop and mobile browsers without requiring an app-store install, and supports Windows, macOS, iOS, and Android devices via Chrome, Safari, Firefox, and Edge. Core capabilities include condition-specific exercise video libraries, health information modules, and longitudinal tracking of pain levels and training duration visualized as progress graphs, with FHIR-compliant export to the German electronic patient record (ePA) and PDF export. The product is anchored clinically by co-founder Dr. Daniel Wagner, a former orthopedic and sports medicine physician at the Olympic Training Center Stuttgart, and reinforced through partnerships with clinics such as Asklepios Sportklinik Lindenlohe.

The revenue model is dual-track. For statutory insured patients with covered diagnoses, full cost is reimbursed by the Krankenkasse at €0 to the patient. For privately insured patients and self-pay, the program is sold as a one-time license at €119. Distribution is anchored by physician prescriptions delivered via a doctor-referral / DiGA-prescription pathway, supplemented by a free Rezept-Service that assists patients with insurance submission, and a self-serve browser-based activation flow. The company is privately held, headquartered in Valley/Oberlaindern, Bavaria, with 11-50 employees and a cumulative track record of 70,000+ prescribed therapy programs to date.

Name

Mawendo

Legal name

Mawendo GmbH

Website

https://mawendo.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Mawendo provides a browser-based 12-week digital therapy program (DiGA) for orthopedic rehabilitation, prescribed by German physicians, reimbursed by statutory health insurance for M22 indications, and priced at €119 for self-payers. The company serves orthopedic patients with evidence-based home exercise therapy grounded in German specialty society guidelines.

Ownership category

akta.pro rank

Product category

Digital Health / Digital Therapeutics - Orthopedic Rehabilitation Software

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Health Services (8000)

akta.pro primary industry

Virtual PT/OT/MSK & Rehab Programs (Payer-Sponsored) (HLALACAI)

akta.pro secondary industry

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)

Keywords

• Digital therapy programs
• Orthopedic rehabilitation
• Medical device software
• Home exercise therapy
• Health insurance billing

Headquarters

HQ city

Stuttgart

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Statutory Health Insurance Reimbursement: Statutory health insurance (gesetzliche Krankenversicherung) covers the full cost (0€) for patients with reimbursable diagnoses. Patients receive a free activation code from their health insurer after submitting their doctor's prescription.
2. Private Insurance and Self-Pay: One-time payment of 119€ for privately insured patients and self-pay customers. No statutory reimbursement claim exists for this segment; patients should clarify cost coverage with their private insurer beforehand.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Mawendo operates the Mawendo Therapieprogramm, a 12-week web-based digital health application (DiGA / Digitale Gesundheitsanwendung) that delivers doctor-prescribed, evidence-based exercise therapy programs for orthopedic rehabilitation. Patients receive a personalized, condition-specific training plan structured in three progressive phases, with exercise videos, health information, and pain/training documentation accessible through a web browser. The product is CE-marked as a Class I medical device and is reimbursed by German statutory health insurance for qualifying diagnoses such as M22 (patellar diseases), with direct self-pay/private insurance available at €119.

Product overview

Mawendo is a single unified digital health application (DiGA - Digitale Gesundheitsanwendung) designed for orthopedic rehabilitation. The core product is the Mawendo Therapieprogramm, a 12-week web-based therapy program delivered through browser access. It provides indication-specific training programs with exercise videos, health information, and documentation features for tracking pain levels and training duration. The program is structured in three progressive phases and covers various orthopedic conditions across body regions including knee, shoulder, hip, ankle, elbow, spine, and foot.

Differentiator

Problem solved

Functional benefit

Products and services

• Mawendo Therapieprogramm A 12-week web-based digital therapy program (DiGA - Digitale Gesundheitsanwendung) for orthopedic rehabilitation delivered through any modern web browser without app installation. It provides indication-specific training programs with exercise videos, health information, and documentation features (pain levels and training duration visualized in progress graphs) structured in three progressive phases for diagnoses across the knee, shoulder, hip, elbow, spine, ankle, and foot. Prescribed by physicians, with reimbursement via statutory health insurance for covered diagnoses (e.g., M22 - diseases of the patella) and a one-time €119 fee for self-pay/private insurance patients. Class I medical device (Medizinprodukt Risikoklasse 1) with CE marking.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record.

• Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU)Strategic or Co-development Partner
• Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA)Strategic or Co-development Partner
• Deutsche Vereinigung für Schulter- und Ellenbogenchirurgie (DVSE)Strategic or Co-development Partner
• Deutsche Kniegesellschaft (DKG)Strategic or Co-development Partner
• Deutsche Assoziation für Fuß und Sprunggelenk (DAF)Strategic or Co-development Partner
• Asklepios Sportklinik LindenlocheStrategic or Co-development Partner

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Curalie: Curalie is a German digital health platform offering clinician-supervised home exercise and prevention programs, intersecting with Mawendo's MSK rehabilitation use case across a broader multi-condition portfolio.

Direct peers

• Selfapy: Selfapy is a Berlin-based DiGA offering doctor-prescribed digital therapeutic courses, including for back pain and orthopedic conditions, sharing Mawendo's regulatory and reimbursement framework.
• Physitrack: Physitrack is a global physiotherapy exercise prescription and patient adherence platform used by clinicians to deliver home exercise programs, comparable to Mawendo's content, video, and documentation stack.
• Caspar Health: Caspar Health is a Berlin-based digital rehabilitation platform offering clinician-prescribed exercise programs for orthopedic and other conditions, directly comparable to Mawendo's prescription-led rehab model.
• Kaia Health: Kaia Health offers an MSK digital therapy app with exercise-based programs for pain management, targeting the same orthopedic self-management and home-rehabilitation use cases as Mawendo.
• Vivira: Vivira is a listed German DiGA providing doctor-prescribed home exercise therapy for back pain, directly competing with Mawendo for the same orthopedic prescription pathway and statutory reimbursement model.

Broad incumbents

• Hinge Health: Hinge Health is a US digital MSK clinic combining app-based exercise therapy with coach and clinician oversight, representing a scaled incumbent version of Mawendo's orthopedic digital-care model.
• Sword Health: Sword Health is a global digital MSK care provider pairing AI-driven exercise programs with licensed clinicians, comparable in scope to Mawendo but operating at much greater scale and broader geographic footprint.

Regional players

• HelloBetter: HelloBetter is a Hamburg-based DiGA-focused digital therapeutics company offering doctor-prescribed online courses; while it focuses on mental rather than orthopedic indications, it operates in the same German DiGA regulatory and reimbursement infrastructure as Mawendo.
• MoveUP: MoveUP is a European (Belgium-led) digital physiotherapy platform offering reimbursed home-based rehab programs, comparable to Mawendo in model and content but operating under Belgium's mHealth reimbursement framework rather than DiGA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mawendo-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mawendo